[Captiv8 in PRWeek] Captiv8 teams up with Brandr Group for NIL program
The partnership will provide measurement, analytics and full-funnel reporting for name, image and likeness group licensing campaigns. Read...
Read MoreAuthor: OurCrowd
[DarioHealth in Vents Magazine] Dario blood glucose meter available at Canada’s trusted online pharmacy
Living with diabetes requires consistent monitoring of blood glucose levels to ensure proper management and overall health. In Canada, the Dario Blood Glucose Meter has emerged as a reliable and convenient tool for individuals with diabetes. This article explores the benefits of the Dario Blood Glucose Meter and highlights its availability through reputable Canada online pharmacy. Read more...
Read More[DailyPay in EIN Newswires] Yoke’s fresh markets partners with DailyPay to provide financial wellness benefit to team members
NEW YORK, NEW YORK, UNITED STATES, August 17, 2023/EINPresswire.com/ — Yoke’s Fresh Markets (Yoke’s), an employee-owned Washington-based chain of grocery stores, has partnered with DailyPay – the leading provider of on-demand pay. Through this partnership, Yoke’s employees can access their pay immediately after completing a shift, empowering employees to pay bills, invest, spend and save on their own schedule. Read...
Read More[Cybersixgill in Accesswire] Cybersixgill named finalist of the coveted top InfoSec Innovator Awards for 2023
TEL AVIV, ISRAEL / ACCESSWIRE / August 17, 2023 / Cybersixgill, the global cyber threat intelligence data provider, announced today that it has been named a finalist for the following award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine: Innovators Award for Threat Intelligence. Read more...
Read More[Alpha Tau in GlobeNewswire] Alpha Tau announces robust long-term safety and efficacy data from multiple clinical trials of Alpha DaRT
JERUSALEM, Aug. 17, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today initial long-term safety and tumor control outcomes for patients with unresectable, recurrent, or locally advanced head and neck or skin tumors treated Alpha DaRT across four prospective trials conducted at several international institutions. Read...
Read More
